Ferric Ammonium Citrate is indicated for the prevention and treatment of iron deficiency anemia. It is commonly used in patients who cannot tolerate or absorb oral iron supplements or when oral iron therapy is ineffective.

Anemia

• The dosage of Ferric Ammonium Citrate should be individualized based on the patient's age, weight, and iron deficiency severity.
• The medication is administered intravenously and should be given by a healthcare professional trained in the administration of iron supplements.
• The recommended dose and frequency of administration will depend on the patient's iron deficiency status and the specific product formulation.

Adverse reactions to Ferric Ammonium Citrate may occur and can include:

• Local reactions at the injection site, such as pain, inflammation, or discoloration
• Allergic reactions, including rash, itching, or swelling
• Nausea or vomiting
• Diarrhea or constipation
• Abdominal discomfort or pain
• Headache
• Dizziness

Pain at injection site

Nausea

Constipation

Headache

• Ferric Ammonium Citrate should be used with caution in patients with a history of hypersensitivity or allergic reactions to iron supplements or any of its components.
• The medication should be administered slowly and at a rate recommended by the manufacturer to minimize the risk of adverse reactions, especially during the initial infusion.
• Regular monitoring of the patient's iron levels, blood count, and renal function is essential during treatment with Ferric Ammonium Citrate.
• Iron overload can occur with excessive or prolonged use of iron supplements. Patients with hereditary hemochromatosis or other conditions predisposing them to iron overload should be closely monitored.
• Ferric Ammonium Citrate should not be used as a substitute for correcting underlying causes of iron deficiency, such as gastrointestinal bleeding or inadequate dietary intake.